Misinformation and mistrust are two of the biggest culprits behind minority groups’ reluctance to participate in COVID-19 trials, but community outreach, education and replacing fake “facts” with real ones are the first steps in easing their fear of clinical research. Read More
Sponsors and CROs are not embracing the kinds of progressive quality management methods, such as predictive quality metrics, quality tolerance limits and automated metric dashboards, encouraged by regulators, according to a new survey that found the two groups share a perception that such tools are less effective than traditional methods. Read More